Braxia Scientific (BRAX.C) announced they will be conducting a randomized clinical trial that will involve giving patients multiple doses of psilocybin. Braxia says this is Canada’s first psilocybin trial…
brax.c
Braxia Scientific’s (BRAX.C) CEO Dr. Roger McIntyre and Chief Medical and Scientific Officer Dr. Josh Rosenblat have received $918,000 from the Canadian Institutes of Health Research (CIHR), the Government of Canada’s federal funding agency…
Esketamine Braxia Scientific (BRAX.C), formerly known as Champignon Brands had a rough 2020. It was a down year for many of us, but Champignon really found itself in trouble…